Atopic Dermatitis with Multiple Comorbidities Treated with Dupilumab. A Case Report and Review of the Literature Regarding the Safety of Dupilumab

Dupilumab is the only available biological treatment for moderate-to-severe atopic dermatitis (AD). Even so, limited clinical data regarding its safety profile are available. Interactions with other drugs and the adverse effects of Dupilumab on patients with multiple comorbidities, such as chronic h...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitroi, George G., Stoica, Loredana Elena, Mitroi, George F., Mitroi, Mihaela Roxana, Tutunaru, Cristina Violeta, Ică, Oana Maria, Ianoși, Laura Simona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605392/
https://www.ncbi.nlm.nih.gov/pubmed/36295105
http://dx.doi.org/10.3390/life12101670

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605392/
https://www.ncbi.nlm.nih.gov/pubmed/36295105
http://dx.doi.org/10.3390/life12101670

Ejemplares similares